Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer

详细信息    查看全文

• 作者：Haoming Xu^a ; ¹ ; ^{hx228@cam.ac.uk" class="auth_mail" title="E-mail the corresponding author} ; Mohammad Ali Moni^a ; ^b ; ¹ ; ^{m.moni@garvan.org.au" class="auth_mail" title="E-mail the corresponding author} ; Pietro Liò ; ^a ; ^{pl219@cam.ac.uk" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Comorbidity ; Network regularised Cox regression ; Multiplex network ; Survival prediction ; Cancer
• 刊名：Computational Biology and Chemistry
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：59
• 期：part_PB
• 页码：15-31
• 全文大小：4072 K

文摘

In cancer genomics, gene expression levels provide important molecular signatures for all types of cancer, and this could be very useful for predicting the survival of cancer patients. However, the main challenge of gene expression data analysis is high dimensionality, and microarray is characterised by few number of samples with large number of genes. To overcome this problem, a variety of penalised Cox proportional hazard models have been proposed. We introduce a novel network regularised Cox proportional hazard model and a novel multiplex network model to measure the disease comorbidities and to predict survival of the cancer patient. Our methods are applied to analyse seven microarray cancer gene expression datasets: breast cancer, ovarian cancer, lung cancer, liver cancer, renal cancer and osteosarcoma. Firstly, we applied a principal component analysis to reduce the dimensionality of original gene expression data. Secondly, we applied a network regularised Cox regression model on the reduced gene expression datasets. By using normalised mutual information method and multiplex network model, we predict the comorbidities for the liver cancer based on the integration of diverse set of omics and clinical data, and we find the diseasome associations (disease–gene association) among different cancers based on the identified common significant genes. Finally, we evaluated the precision of the approach with respect to the accuracy of survival prediction using ROC curves. We report that colon cancer, liver cancer and renal cancer share the CXCL5 gene, and breast cancer, ovarian cancer and renal cancer share the CCND2 gene. Our methods are useful to predict survival of the patient and disease comorbidities more accurately and helpful for improvement of the care of patients with comorbidity. Software in Matlab and R is available on our GitHub page: https://github.com/ssnhcom/NetworkRegularisedCox.git.